Back
Aligos Therapeutics, Inc. Stock Price Chart
BlackRock's $91B Secret
Learn how to access Native Markets before Coinbase. Watch the free training.
Buy
55
ALGS
Aligos Therapeutics, Inc.
Last Price:
$8.43
Seasonality Move:
-29.93%
7 Day Trial
ALL ACCESS PASS
$
7
Get Paid In ANY Crypto Market
Learn the crash-proof system. Watch the free training.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALGS is experiencing slight buying pressure.
Aligos Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.07 | Sell |
| 20-day SMA: | 10.59 | Sell |
| 50-day SMA: | 9.27 | Buy |
| 200-day SMA: | 8.33 | Buy |
| 8-day EMA: | 9.96 | Sell |
| 20-day EMA: | 10.15 | Sell |
| 50-day EMA: | 9.74 | Sell |
| 200-day EMA: | 10.51 | Sell |
Aligos Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 44.22 | Sell |
| Chaikin Money Flow: | 3614 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.41 - 11.37) | Sell |
| Bollinger Bands (100): | (8.16 - 10.92) | Sell |
Aligos Therapeutics, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aligos Therapeutics, Inc. Stock
Is Aligos Therapeutics, Inc. Stock a Buy?
-
Aligos Therapeutics, Inc. share price is 9.32 while ALGS 8-day simple moving average is 10.07, which is a Sell signal.
-
The stock price of ALGS is 9.32 while Aligos Therapeutics, Inc. 20-day SMA is 10.59, which makes it a Sell.
-
Aligos Therapeutics, Inc. 50-day simple moving average is 9.27 while ALGS share price is 9.32, making it a Buy technically.
-
ALGS stock price is 9.32 and Aligos Therapeutics, Inc. 200-day simple moving average is 8.33, creating a Buy signal.
ALGS Technical Analysis vs Fundamental Analysis
Buy
55
Aligos Therapeutics, Inc. (ALGS)
is a Buy
Is Aligos Therapeutics, Inc. a Buy or a Sell?
-
Aligos Therapeutics, Inc. stock is rated a BuyThe current Aligos Therapeutics, Inc. [ALGS] share price is $9.32. The Score for ALGS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Aligos Therapeutics, Inc. Stock Info
Market Cap:
52M
Price in USD:
9.32
Share Volume:
54.2K
Aligos Therapeutics, Inc. 52-Week Range
52-Week High:
46.80
52-Week Low:
3.76
Buy
55
Aligos Therapeutics, Inc. (ALGS)
is a Buy
Aligos Therapeutics, Inc. Share Price Forecast
-
What is the Aligos Therapeutics, Inc. stock price today?The Aligos Therapeutics, Inc. stock price is 9.32 USD today.
-
Will ALGS stock go up or go down?Aligos Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Aligos Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aligos Therapeutics, Inc. is not overvalued.
Is Aligos Therapeutics, Inc. Stock a Buy?
-
Aligos Therapeutics, Inc. share price is 9.32 while ALGS 8-day exponential moving average is 9.96, which is a Sell signal.
-
The stock price of ALGS is 9.32 while Aligos Therapeutics, Inc. 20-day EMA is 10.15, which makes it a Sell.
-
Aligos Therapeutics, Inc. 50-day exponential moving average is 9.74 while ALGS share price is 9.32, making it a Sell technically.
-
ALGS stock price is 9.32 and Aligos Therapeutics, Inc. 200-day simple moving average is 10.51, creating a Sell signal.
Fundamental Analysis of Aligos Therapeutics, Inc.
Is Aligos Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and an increase next year of $0.60 per share.
Technical Analysis of Aligos Therapeutics, Inc.
Should I short Aligos Therapeutics, Inc. stock?
-
ALGS Moving Average Covergence Divergence (MACD) indicator is 0.1, suggesting Aligos Therapeutics, Inc. is a Buy
-
Aligos Therapeutics, Inc. Relative Strength Index (RSI) is 44.22, which suggest Aligos Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Aligos Therapeutics, Inc. is (9.41 - 11.37), which suggest Aligos Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Aligos Therapeutics, Inc. is (8.16 - 10.92), which suggest Aligos Therapeutics, Inc. is a Sell
* Aligos Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.